A randomized study from Insulet of adults and children with Type 1 diabetes found that moving from multiple daily injections ...

Corporation shared new Omnipod 5 clinical data from its RADIANT study. Results from this multinational randomized controlled ...

Insulet Corporation’s RADIANT study shows glycaemic improvements with Omnipod 5 automated insulin delivery system: Action, Massachusetts Friday, March 21, 2025, 18:00 Hrs [IST] ...

Participants began with an average HbA1c level of 8.1%. After three months, people who used Omnipod 5 improved HbA1c by an ...

Insulet unveils positive RADIANT trial clinical data for its Omnipod 5 at the 18th international conference on ATTD.

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c at 30 weeks ... the burden of RSV on young children and their guardians ...

Technosphere insulin, a rapid-acting human insulin administrated through an inhaler, was associated with reductions in HbA1c ...

A clinical trial led by researchers at the Ca' Granda Ospedale Maggiore Policlinico and the University of Milan found a ...

Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...

Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin-producing cells in the ...

Although current federal budget considerations create much uncertainty concerning future Medicaid funding and program changes ...